Tomomi Sudo

Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients

Toshiaki Hitomi, Toshiyuki Habu, Hatasu Kobayashi et al. · Biochemical and Biophysical Research Communications · 2013 · 127 citations

Life Sciences, Molecular Medicine, Cardiovascular Genetics +11

Cell aggregation optimizes the differentiation of human ESCs and iPSCs into pancreatic bud-like progenitor cells

Tarō Toyoda, Shin-Ichi Mae, Hiromi Tanaka et al. · Stem Cell Research · 2015 · 105 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +16

The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality

Toshiaki Hitomi, Toshiyuki Habu, Hatasu Kobayashi et al. · Biochemical and Biophysical Research Communications · 2013 · 61 citations

Life Sciences, Genetics, Molecular Genetics +14

Identification of a small molecule that facilitates the differentiation of human iPSCs/ESCs and mouse embryonic pancreatic explants into pancreatic endocrine cells

Yasushi Kondo, Tarō Toyoda, Ryo Ito et al. · Diabetologia · 2017 · 40 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17

Insulin‐producing cells derived from ‘induced pluripotent stem cells’ of patients with fulminant type 1 diabetes: Vulnerability to cytokine insults and increased expression of apoptosis‐related genes

Yoshiya Hosokawa, Tarō Toyoda, Kenji Fukui et al. · Journal of Diabetes Investigation · 2017 · 31 citations · Full text

Life Sciences, Cell Biology, Endocrinology +17